Ravinder Sawhney

Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer

Charles Butts, Nevin Murray, Andrew W. Maksymiuk et al. · Journal of Clinical Oncology · 2005 · 421 citations · Full text

Medicine, Immunology, Oncology +17

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

Charles Butts, Andrew W. Maksymiuk, Glenwood Goss et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 197 citations · Full text

Medicine, Immunology, Oncology +17

B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis

Charles Butts, Andrew W. Maksymiuk, Glenwood Goss et al. · Journal of Thoracic Oncology · 2007 · 47 citations · Full text

Medicine, Immunology, Oncology +15

Thoracic epidural analgesia in obese patients with body mass index of more than 30 kg/m² for off pump coronary artery bypass surgery

Mayank Vats, Munish Sharma, Yatin Mehta et al. · Annals of Cardiac Anaesthesia · 2010 · 41 citations · Full text

Medicine, Anesthesiology, Surgery +16

Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer

Ana Elisa Lohmann, Judy-Anne W. Chapman, Margot J. Burnell et al. · Breast Cancer Research and Treatment · 2015 · 21 citations

Medicine, Oncology, Breast Oncology +15